Six names hit the tape today, every one of them a household word, and the market said thank you by selling most of them.

Six names hit the tape today, every one of them a household word, and the market said thank you by selling most of them.

Johnson and Johnson leads because it leads in pain. The gap down five point seven percent is the headline, but the number that actually matters is earnings per share down seven point seven percent year over year on revenue that grew eight point one percent. You grew the top line and shrank the bottom — that is a margin story, and not a good one. The Street priced this at a price-to-earnings of thirty point one coming in, which is a premium multiple that assumes execution. When execution slips and earnings per share contracts while peers hold, that premium evaporates fast and does not always come back at the same speed it left.

Now the banks, because four of them reported the same morning and the market barely flinched on three of them, which is its own signal.

Citigroup gapped down five point six percent despite revenue nearly doubling year over year. That ninety-nine point two percent revenue growth sounds like a transformation story until you realize what base you are growing off — this is a base-effect print, not a business-model print, and the Street apparently knew the difference before the open.

Wells Fargo dropped three point one percent on earnings per share growth of sixteen point nine percent and a net margin of twenty-two point two percent. Solid numbers, moderate punishment — the gap tells you guidance or credit commentary landed softer than the headline.

JPMorgan barely moved, down less than one percent, which is the market giving a standing ovation in bank terms. Net margin of thirty-three point three percent on revenue up over one hundred percent year over year, earnings per share up nineteen point five. At a price-to-earnings of thirteen point seven that is not an expensive bank — it is a toll road with a moat.

Goldman Sachs essentially flatlined on the print, and the number to hold onto is earnings per share up forty-one point seven percent against revenue growth of only six point seven percent. That spread tells you everything about operating leverage — Goldman wrung dramatically more profit out of nearly the same revenue base, and most of the morning coverage missed that entirely.

Then there is UnitedHealth. Net margin of three point one percent, earnings per share down thirty-two point seven percent year over year, and the market barely reacted at the open. That earnings-per-share collapse is not noise — medical cost ratios have been running structurally hotter than the company modeled, which means the actuarial assumptions embedded in their pricing are broken, and repricing insurance books takes years not quarters. A price-to-earnings of twenty-three point nine on a business printing three-percent margins and shrinking earnings is a number that deserves a second look.

Coming days I will go deep on two of these. Johnson and Johnson gets the full margin teardown — there is a story inside that revenue-grows-earnings-shrink dynamic that is worth a dedicated session. And UnitedHealth, because a one-third drop in earnings per share at this scale with that margin profile is not a bad quarter. It is a structural conversation.

That is the menu. The numbers were always there — most people just do not look. See you at the next filing.